Can Portal Hypertension Testing Go Non-invasive?
Combining routine laboratory findings with elastography and imaging may improve diagnostic triage
Clinical Scorecard: Can Portal Hypertension Testing Go Non-invasive?
At a Glance
| Category | Detail |
|---|
| Condition | Portal Hypertension |
| Key Mechanisms | Increased pressure in the portal venous system due to chronic liver disease. |
| Target Population | Patients with chronic liver disease at risk for portal hypertension. |
| Care Setting | Clinical assessment and management of liver disease. |
Key Highlights
- Non-invasive tests may help identify portal hypertension and guide further testing.
- Clinically significant portal hypertension (CSPH) is defined by a hepatic venous pressure gradient (HVPG) of at least 10 mmHg.
- Transient elastography and spleen stiffness measurements can improve diagnostic accuracy.
- Current Baveno VII criteria utilize liver stiffness and platelet count for CSPH assessment.
- AI models show promise for combining imaging and laboratory data for CSPH identification.
Guideline-Based Recommendations
Diagnosis
- HVPG measurement is the reference standard for diagnosing portal hypertension.
- Liver stiffness measurements and platelet counts are used to estimate CSPH likelihood.
Management
- Consider additional testing for patients with indeterminate results from non-invasive assessments.
Monitoring & Follow-up
- Routine laboratory tests may assist in the assessment of portal hypertension.
Risks
- Portal hypertension can lead to complications such as variceal bleeding, ascites, and hepatic encephalopathy.
Patient & Prescribing Data
Patients with chronic liver disease.
Non-invasive tests can help stratify risk and determine the need for invasive procedures.
Clinical Best Practices
- Utilize non-invasive tests for initial risk assessment in portal hypertension.
- Follow a stepwise approach for further testing based on initial results.
Related Resources & Content
